Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference

Josep M. Llovet; Augusto Villanueva; Jorge A. Marrero; Myron Schwartz; Tim Meyer; Peter R. Galle; Riccardo Lencioni; Tim F. Greten; Masatoshi Kudo; Sumithra J. Mandrekar; Andrew X. Zhu; Richard S. Finn; Lewis R. Roberts

doi:10.1002/hep.31327

Related publications

Article2008

Re: Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma

Josep M. Llovet, Gregory J. Gores

JNCI Journal of the National Cancer Institute

Article2001

Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference

Jordi Bruix, Morris Sherman, Josep M. Llovet, Michel Beaugrand, Riccardo Lencioni, Andrew K. Burroughs, Erik Christensen, Luigi Pagliaro, Massimo Colombo, Juan Rodés

Journal of Hepatology

Article2021

Hepatocellular carcinoma

Josep M. Llovet, Robin Kate Kelley, Augusto Villanueva, Amit G. Singal, Eli Pikarsky, Sasan Roayaie, Riccardo Lencioni, Kazuhiko Koike, Jessica Zucman‐Rossi, Richard S. Finn

Nature Reviews Disease Primers

Chapter in a book2006

Hepatocellular Carcinoma

Jordi Bruix, C. Bru, Josep M. Llovet

Article2016

Hepatocellular carcinoma

Josep M. Llovet, Jessica Zucman‐Rossi, Eli Pikarsky, Bruno Sangro, M. Schwartz, Morris Sherman, Gregory J. Gores

Nature Reviews Disease Primers

Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference

Abstract

Discussion(0)

Related publications

Re: Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma

Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference

Hepatocellular carcinoma

Hepatocellular Carcinoma

Hepatocellular carcinoma